Clinical Trial Update: Oral Vitamin D Treatment for the Prevention of Hepatocellular Carcinoma [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating oral vitamin D (cholecalciferol) to prevent hepatocellular carcinoma in patients with Hepatitis B. The study is not yet recrui…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B
• Hepatocellular Carcinoma

Drugs mentioned

• Vitamin D3 (Cholecalciferol)

Snippet

Sponsor: Third Affiliated Hospital, Sun Yat-Sen University | Conditions: Hepatitis B, Carcinoma, Hepatocellular | Phase 4 | Status: NOT_YET_RECRUITING